Page 43 - 21st Century Perspective - Glaucoma Supplement
P. 43
Rhopressa, which is preserved with 0.015% BAK, comes in a 4-mL opaque bottle filled to 2.5 mL. It
is to be dosed once daily in the evening. In phase 3 studies, Rhopressa performed similarly to
timolol, reducing IOP by about 5 mm Hg. Where Rhopressa will fit into the flow chart of therapeutic
intervention is yet to be determined. Its 53% rate of conjunctival hyperemia may be a limiting factor
in its use. Obviously, we will all need a year or so to assess its role in glaucoma patient care.
43
